β1,6-branched oligosaccharides regulate melanin content and motility in macrophage-melanoma fusion hybrids

Melanoma Research

Volumn 17, Issue 1, 2007, Pages 9-16

  Chakraborty, Ashok K ^a   Pawelek, John ^a,b  

^a YALE CANCER CENTER   (United States)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

GnT III; GnT V; Macrophage melanoma fusion hybrids; Melanogenesis; Motility

Indexed keywords

MELANIN; N ACETYLGLUCOSAMINYLTRANSFERASE; OLIGOSACCHARIDE; ALPHA 1,6 MANNOSYLGLYCOPROTEIN BETA 1,6 N ACETYLGLUCOSAMINYLTRANSFERASE; ALPHA-1,6-MANNOSYLGLYCOPROTEIN BETA 1,6-N-ACETYLGLUCOSAMINYLTRANSFERASE; BETA 1,4 MANNOSYL GLYCOPROTEIN BETA 1,4 N ACETYLGLUCOSAMINYLTRANSFERASE; BETA-1,4-MANNOSYL-GLYCOPROTEIN BETA-1,4-N-ACETYLGLUCOSAMINYLTRANSFERASE; MESSENGER RNA; MONOPHENOL MONOOXYGENASE; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL MOTILITY; CHEMOTAXIS; CONTROLLED STUDY; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HYBRID CELL; MACROPHAGE; MELANOCYTE; MELANOGENESIS; MELANOMA; MELANOMA CELL; METASTASIS; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; UPREGULATION; ANIMAL; CELL FUSION; CELL MOTION; CYTOLOGY; DBA MOUSE; DRUG EFFECT; GENETICS; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ANIMALS; CELL FUSION; CELL MOVEMENT; HUMANS; HYBRID CELLS; MACROPHAGES; MELANINS; MELANOMA; MICE; MICE, INBRED DBA; MONOPHENOL MONOOXYGENASE; N-ACETYLGLUCOSAMINYLTRANSFERASES; OLIGOSACCHARIDES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TRANSFECTION;

EID: 33846448535     PISSN: 09608931     EISSN: None     Source Type: Journal    
DOI: 10.1097/CMR.0b013e3280114f34     Document Type: Article

References (76)

1. Yamashita K, Ohkura T, Tachibana Y, Takasaki S, Kobata A. Comparative study of the oligosaccharides released from baby hamster kidney cells and their polyoma transformant by hydrazinolysis. J Biol Chem 1984; 259:10834-10840.
2. Brockhausen I, Narasimhan S, Schachter H. The biosynthesis of highly branched N-glycans: studies on the sequential pathway and functional role of N-acetylglucosaminyltransferases I, II, III, IV, V and VI. Biochimie 1988; 70:1521-1533.
3. Hakomori S. Tumor malignancy defined by aberrant glycosylation and sphingo(glyco)lipid metabolism. Cancer Res 1996; 56:5309-5318.
4. Taniguchi N, Miyoshi E, Ko JH, Ikeda Y, Ihara Y. Implication of N-acetylglucosaminyltransferases III and V in cancer: gene regulation and signaling mechanism. Biochim Biophys Acta 1999; 1455:287-300.
5. Handerson T, Camp R, Harigopal M, Rimm D, Pawelek J. β-6-Branched oligosaccharides are associated with metastasis and predict poor outcome in breast carcinoma. Clin Can Res 2005; 11:2969-2973.
6. Pawelek J. Tumor cell fusion as a source of myeloid traits in cancer. Lancet Oncol 2005; 6:988-993.
7. Pawelek J, Chakraborty A, Lazova R, Yilmaz Y, Cooper D, Brash D, Handerson T. Co-opting macrophage traits in cancer progression: a consequence of tumor cell fusion? In: Dittmar T, Zaenker KS, Schmidt A, editors. Infection and inflammation: impacts on oncogenesis. Vol. 13. Basel: Karger; 2006. pp. 138-155.
8. Rachkovsky M, Sodi S, Chakraborty AK, Avissar Y, Bolognia J, Madison-McNiff J, et al. Melanoma x macrophage hybrids with enhanced metastatic potential. Clin Exp Metastasis 1998; 16:299-312.
9. Sodi SA, Chakraborty AK, Platt JT, Rosemblat S, Keh-Yen A, Bolognia JL, et al. Melanoma x macrophage fusion hybrids acquire increased melanogenesis and metastatic potential: altered N-glycosylation as an underlying mechanism. Pigment Cell Res 1998; 11:299-309.
10. Pawelek JM, Chakraborty AK, Rachkovsky M L, Orlow SJ, Bolognia JL, Sodi SA. Altered N-glycosylation in macrophage x melanoma fusion hybrids. Cell Mol Biol 1999; 45:1011-1027.
11. Chakraborty AK, Sodi S, Rachkovsky M, Kolesnikova N, Platt JT, Bolognia JL, et al. A spontaneous murine melanoma lung metastasis comprised of host x tumor hybrids. Cancer Res 2000; 60:2512-2519.
12. Pawelek J. Tumour cell hybridization and metastasis revisited. Melanoma Res 2000; 10:507-514.
13. Rachkovsky M, Pawelek J. Acquired melanocyte stimulating hormone-inducible chemotaxis following macrophage fusion with Cloudman S91 melanoma cells. Cell Growth Differ 1999; 10:515-524.
14. Hu F, Pasztor LM. In vivo hybridization of cultured melanoma cells and isogenic normal mouse cells. Differentiation 1975; 4:93-97.
15. Halaban R, Nordlund J, Francke U, Moellmann G, Eisenstadt JM. Supermelanotic hybrids derived from mouse melanomas and normal mouse cells. Somatic Cell Genetics 1980; 6:29-44.
16. Laferte S, Dennis JW. Purification of two glycoproteins expressing β1-6 branched Asn-linked oligosaccharides from metastatic tumour cells. Biochem J 1989; 259:569-576.
17. Fukuda M. Lysosomal membrane glycoproteins. J Biol Chem 1991; 15:21327-21330.
18. Chakraborty AK, Pawelek JM. GnT-V, macrophages, and cancer metastasis: a common link. Clin Exp Metastasis 2003; 20:365-373.
19. Chakraborty AK, Pawelek J, Ikeda Y, Miyoshi E, Kolesnikova N, Funasaka Y, et al. Fusion hybrids with macrophage and melanoma cells up-regulate N-acetylglucosaminyl transferase V, β1-6 branching, and metastasis. Cell Growth Differentiation 2001; 12:623-630.
20. Ihara Y, Nishikawa A, Tohma T, Soejima H, Niikawa N, Taniguchi N. cDNA cloning, expression, and chromosomal localization of human N acetylglucosaminyltransferase III (GnT-III). J Biochem (Tokyo) 1993; 113:692-698.
21. Schachter H. Biosynthetic controls that determine the branching and microheterogeneity of protein-bound oligosaccharides. Biochem Cell Biol 1986; 64:163-181.
22. Shibukawa Y, Takahashi M, Laffont I, Honke K, Taniguchi N. Down-regulation of hydrogen peroxide-induced PKC delta activation in N-acetylglucosaminyltransferase III-transfected HeLaS3 cells. J Biol Chem 2003; 278:3197-3203.
23. Yoshimura M, Nishikawa A, Ihara Y, Taniguchi S, Taniguchi N. Suppression of lung metastasis of B-16 mouse melanoma by N- acetylglucosaminyltransferase III gene transfection. Proc Natl Acad Sci USA 1995; 92:8754-8758.
24. Guo HB, Lee I, Kamar M, Akiyama SK, Pierce M. Aberrant N-glycosylation of beta1 integrin causes reduced alpha5beta1 integrin clustering and stimulates cell migration. Cancer Res 2002; 62:6837-6845.
25. Isaji T, Gu J, Nishiuchi R, Zhao Y, Takahashi M, Miyoshi E, et al. Introduction of bisecting GlcNAc into integrin alpha5beta1 reduces ligand binding and down-regulates cell adhesion and cell migration. J Biol Chem 2004; 279:19747-19754.
26. Guo HB, Lee I, Kamar M, Pierce M. N-acetylglucosaminyltransferase V expression levels regulate cadherin-associated homotypic cell-cell adhesion and intracellular signaling pathways. J Biol Chem 2003; 278:52412-52424.
27. Yoshimura M, Ihara Y, Matsuzawa Y, Taniguchi N. Aberrant glycosylation of E-cadherin enhances cell-cell binding to suppress metastasis. J Biol Chem 1996; 271:13811-13815.
28. Kitada T, Miyoshi E, Noda K, Higashiyama S, Ihara H, Matsuura N, et al. The addition of bisecting N-acetylglucosamine residues to E-cadherin downregulates the tyrosine phosphorylation of beta-catenin. J Biol Chem 2001; 276:475-480.
29. Sato Y, Takahashi M, Shibukawa Y, Jain SK, Hamaoka R, Miyagawa Ji, et al. Overexpression of N-acetylglucosaminyltransferase III enhances the epidermal growth factor-induced phosphorylation of ERK in HeLaS3 cells by up-regulation of the internalization rate of the receptors. J Biol Chem 2001; 276:11956-11962.
30. Iijima J, Zhao Y, Isaji T, Kameyama A, Nakaya S, Wang X, et al. Cell-cell interaction-dependent regulation of N- acetylglucosaminyltransferase III and the bisected N-glycans in GE11 epithelial cells. Involvement of E-cadherin-mediated cell adhesion. J Biol Chem 2006; 28:13038-13046.
31. Guo P, Wang QY, Guo HB, Shen ZH, Chen HL. N- acetylglucosaminyltransferase V modifies the signaling pathway of epidermal growth factor receptor. Cell Mol Life Sci 2004; 61:1795-1804.
32. Rebbaa A, Yamamoto H, Saito T, Meuillet E, Kim P, Kersey DS, et al. Gene transfection-mediated overexpression of beta1,4- N-acetylglucosamine bisecting oligosaccharides in glioma cell line U373 MG inhibits epidermal growth factor receptor function. J Biol Chem 1997; 272:9275-9279.
33. Gu J, Zhao Y, Isaji T, Shibukawa Y, Ihara H, Takahashi M, et al. Beta1,4-N-acetylglucosaminyltransferase III down-regulates neurite outgrowth induced by costimulation of epidermal growth factor and integrins through the Ras/ERK signaling pathway in PC12 cells. Glycobiology 2004; 14:177-186.
34. Ihara Y, Sakamoto Y, Mihara M, Shimizu K, Taniguchi N. Overexpression of N-acetylglucosaminyltransferase III disrupts the tyrosine phosphorylation of Trk with resultant signaling dysfunction in PC12 cells treated with nerve growth factor. J Biol Chem 1997; 272:9629-9634.
35. Guo HB, Liu F, Chen HL. Increased susceptibility to apoptosis of human hepatocarcinoma cells transfected with antisense N- acetylglucosaminyltransferase V cDNA. Biochem Biophys Res Commun 1999; 264:509-517.
36. Guo P, Chen HJ, Wang QY, Chen HL. Down regulation of N- acetylglucosaminyltransferase V facilitates all-transretinoic acid to induce apoptosis of human hepatocarcinoma cells. Mol Cell Biochem 2006; 284:103-110.
37. Guo HB, Jiang AL, Ju TZ, Chen HL. Opposing changes in N-acetylglucosaminyltransferase-V and -III during the cell cycle and all-trans retinoic acid treatment of hepatocarcinoma cell line. Biochim Biophys Acta 2000; 1495:297-307.
38. Sasai K, Ikeda Y, Ihara H, Honke K, Taniguchi N. Caveolin-1 regulates the functional localization of N-acetylglucosaminyltransferase III within the golgi apparatus. J Biol Chem 2003; 278:25295-25301.
39. Handerson T, Pawelek J. β1,6-branched oligosaccharides and coarse vesicles: a common and pervasive phenotype in melanoma and other human cancers. Cancer Res 2003; 63:5363-5369.
40. Rupani R, Handerson T, Pawelek J. Co-localization of β1,6-branched oligosaccharides and coarse melanin in macrophage-melanoma fusion hybrids and human melanoma cells in vitro. Pigment Cell Res 2004; 17:281-288.
41. Nishikawa A, Ihara Y, Hatakeyama M, Kangawa K, Taniguchi N. Purification, cDNA cloning, and expression of UDP- N-acetylglucosamine: beta-D-mannoside beta-1,4N-acetylglucosaminyltransferase III from rat kidney. J Biol Chem 1992; 267:18199-18204.
42. Pawelek JM. Melanoma cells. In: Jakoby WB, Pastan I, editors. Methods in enzymology. Vol. LVII. New York: Academic Press; 1978. pp. 564-570.
43. Cummings RD, Kornfeld S. Characterization of structural determinants required for the high affinity interaction of asparagine-linked oligosaccharides with immobilized Phaseolus vulgaris leukoagglutinating and erythro agglutinating lectins. J Biol Chem 1982; 257:11230-11234.
44. Yamashita K, Hitoi A, Kobata A. Structural determinants of Phaseolus vulgaris erythroagglutinating lectin for oligosaccharides. J Biol Chem 1983; 258:14753-14755.
45. Mishima Y, Imokawa G. Selective aberration and pigment loss in melanosomes of malignant melanoma cells in vitro by glycosylation inhibitors: premelanosomes as glycoprotein. J Invest Dermatol 1983; 81:106-114.
46. Imokawa G, Mishima Y. Functional analysis of tyrosinase isozymes of cultured malignant melanoma cells during the recovery period following interrupted melanogenesis induced by glycosylation inhibitors. J Invest Dermatol 1984; 83:196-201.
47. Imokawa G, Mishima Y. Analysis of tyrosinases as asparagin-linked oligosaccharides by concanavalin A lectin chromatography: appearance of new segment of tyrosinases in melanoma cells following interrupted melanogenesis induced by glycosylation inhibitors. J Invest Dermatol 1985; 85:165-168.
48. Ohkura T, Yamashita K, Mishima Y, Kobata A. Purification of hamster melanoma tyrosinases and structural studies of their asparagine-linked sugar chains. Arch Biochem Biophys 1984; 235:63-77.
49. Imokawa G, Mishima Y. Loss of melanogenic properties in tyrosinases induced by glucosylation inhibitors within malignant melanoma cells. Cancer Res 1982; 42:1994-2002.
50. Imokawa G, Mishima Y. Importance of glycoproteins in the initiation of melanogenesis: an electron microscopic study of B-16 melanoma cells after release from inhibition of glycosylation. J Invest Dermatol 1986; 87:319-325.
51. Mishima Y, Ichihashi M, Hayashibe K, Ueda M, Hatta S, Funasaka Y, et al. Control of melanogenesis and melanoma oncogenesis. Prog Clin Biol Res 1988; 256:127-141.
52. Takahashi H, Parsons PG. Rapid and reversible inhibition of tyrosinase activity by glucosidase inhibitors in human melanoma cells. J Invest Dermatol 1992; 98:481-487.
53. Petrescu SM, Petrescu A-J, Titu HN, Dwek RA, Platt FM. Inhibition of N-glycan processing in B16 melanoma cells results in inactivation of tyrosinase but does not prevent its transport to the melanosome. J Biol Chem 1997; 272:15796-15803.
54. Negroiu G, Branza-Nichita N, Costin GE, Titu H, Petrescu AJ, Dwek RA, et al. Investigation of the intracellular transport of tyrosinase and tyrosinase related protein (TRP)-1. The effect of endoplasmic reticulum (ER)-glucosidases inhibition. Cell Mol Biol (Noisy-le-grand) 1999; 45:1001-1010.
55. Negroiu G, Branza-Nichita N, Petrescu AJ, Dwek RA, Petrescu SM. Protein specific N-glycosylation of tyrosinase and tyrosinase-related protein-1 in B16 mouse melanoma cells. Biochem J 1999; 344:659-665.
56. Branza-Nichita N, Negroiu G, Petrescu AJ, Garman EF, Platt FM, Wormald MR, et al. Mutations at critical N-glycosylation sites reduce tyrosinase activity by altering folding and quality control. J Biol Chem 2000; 275:8169-8175.
57. Branza-Nichita N, Petrescu AJ, Negroiu G, Dwek RA, Petrescu SM. N-glycosylation processing and glycoprotein folding-lessons from the tyrosinase-related proteins. Chem Rev 2003; 100:4697-4712.
58. Mosse CA, Hsu W, Engelhard VH. Tyrosinase degradation via two pathways during reverse translocation to the cytosol. Biochem Biophys Res Commun 2001; 285:313-319.
59. Olivares C, Solano F, Garcia-Borron JC. Conformation-dependent post-translational glycosylation of tyrosinase. Requirement of a specific interaction involving the CuB metal binding site. J Biol Chem 2003; 278:15735-15743.
60. Svedine S, Wang T, Halaban R, Hebert DN. Carbohydrates act as sorting determinants in ER-associated degradation of tyrosinase. J Cell Sci 2004; 117:2937-2949.
61. Lavado A, Olivares C, Garcia-Borron JC, Montoliu L. Molecular basis of the extreme dilution mottled mouse mutation: a combination of coding and noncoding genomic alterations. J Biol Chem 2005; 280:4817-4824.
62. Wang N, Daniels R, Hebert DN. The cotranslational maturation of the type I membrane glycoprotein tyrosinase: the heat shock protein 70 system hands off to the lectin-based chaperone system. Mol Biol Cell 2005; 16:3740-3752.
63. Maresca V, Flori E, Cardinali G, Briganti S, Lombardi D, Mileo AM, Paggi MG, Picardo M. Ferritin light chain down-modulation generates depigmentation in human metastatic melanoma cells by influencing tyrosinase maturation. J Cell Physiol 2006; 206:843-848.
64. Jimbow K, Park JS, Kato F, Hirosaki K, Toyofuku K, Hua C, et al. Assembly, target-signaling and intracellular transport of tyrosinase gene family proteins in the initial stage of melanosome biogenesis. Pigment Cell Res 2000; 13:222-229.
65. Xu Y, Bartido S, Setaluri V, Qin J, Yang G, Houghton AN. Diverse roles of conserved asparagine-linked glycan sites on tyrosinase family glycoproteins. Exp Cell Res 2001; 267:115-125.
66. Aroca P, Martinez-Liarte JH, Solano F, Garcia-Borron JC, Lozano JA. The action of glycosylases on dopachrome (2-carboxy-2,3-dihydroindole-5,6-quinone) tautomerase. Biochem J 1992; 284:109-113.
67. Hornyak TJ, Hayes DJ, Ziff EB. Cell-density-dependent regulation of expression and glycosylation of dopachrome tautomerase/tyrosinase-related protein-2. J Invest Dermatol 2000; 115:106-112.
68. Negroiu G, Dwek RA, Petrescu SM. The inhibition of early N-glycan processing targets TRP-2 to degradation in B16 melanoma cells. J Biol Chem 2003; 278:27035-27042.
69. Yasumoto K, Watabe H, Valencia JC, Kushimoto T, Kobayashi T, Appella E, et al. Epitope mapping of the melanosomal matrix protein gp100 (PMEL17): rapid processing in the endoplasmic reticulum and glycosylation in the early Golgi compartment. J Biol Chem 2004; 279:28330-28338.
70. Roux L, Lloyd KO. Glycosylation characteristics of pigmentation- associated antigen (GP75): an intracellular glycoprotein of human melanocytes and malignant melanomas. Arch Biochem Biophys 1986; 251:87-96.
71. Handerson T, Berger A, Harigopol M, Rimm D, Chikako N, Ueda M, Miyoshi E, et al. Melanophages reside in hypermelanotic, aberrantly glycosylated tumor areas and predict improved outcome in primary CMM. J Clin Pathol (in press).
72. Saleh FH, Crotty KA, Hersey P, Menzies SW, Rahman W. Autonomous histopathological regression of primary tumours associated with specific immune responses to cancer antigens. J Pathol 2003; 200:383-395.
73. Hariri M, Millane G, Guimond M, Guay G, Dennis JW, Nabi IR. Biogenesis of multilamellar bodies via autophagy. Mol Biol Cell 2000; 11:255-268.
74. Guo HB, Zhang QS, Chen HL. Effects of H-ras and v-sis overexpression on N-acetylglucosaminyltransferase V and metastasis-related phenotypes in human hepatocarcinoma cells. J Cancer Res Clin Oncol 2000; 126:263-270.
75. Chakraborty A, Lazova R, Davies S, Bäckvall H, Ponten F, Brash D, et al. Donor DNA in a renal cell carcinoma metastasis from a bone marrow transplant recipient. Bone Marrow Transplant 2004; 34:183-186.
76. Yilmaz Y, Lazova R, Qumsiyeh M, Cooper D, Pawelek J. Donor Y chromosome in renal carcinoma cells of a female BMT recipient. Bone Marrow Transplant 2005; 35:1021-1024.